Skip to main content
Premium Trial:

Request an Annual Quote

Rockland Immunochemcials to Market LIMR's Cell Assays

NEW YORK (GenomeWeb News) – Rockland Immunochemicals said today that it will market LIMR Development's cellular assays for research purposes.

The alliance builds on an earlier agreement between Gilbertsville, Pa.-based Rpckland and LIMR, which is a business development subsidiary of the Lankenau Institute for Medical Research.

Under the new agreement, Rockland will sell LIMR's CellCountEZ, OxPhos, RadDose, and Intracellular ThiolEZ assays.

The CellCountEZ assay measures metabolically active cells while simultaneously quantifying cell death to determine cell viability, cell toxicity, or cellular proliferation. The OxPhos assay is determines the cellular glutathione recycling capacity in tissue culture as well as that of whole blood. The RadDose assay is used for the measurement of ionizing radiation dose rates, and the Intracellular ThiolEZ assay is used to determine total intracellular thiols in studies of the aging, oxidative stress, antioxidant, chemotherapy response, and toxicology processes.

Financial and other terms of the agreement were not disclosed.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.